<DOC>
	<DOC>NCT02759029</DOC>
	<brief_summary>Helicobacter pylori eradication (H. pylori) rates with clarithromycin-based triple therapy are declining, and an alternative strategy is needed urgently. The investigators sought to compare the efficacy of pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy vs. concomitant therapy for H. pylori eradication in a region with high rates of multiple drug resistance.</brief_summary>
	<brief_title>Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test</brief_title>
	<detailed_description />
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>1. positive results of rapid urease test 1. liver cirrhosis, 2. chronic kidney disease, 3. bleeding tendency, 4. pregnant, 5. allergy to antibiotics</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>